Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

NCT03587844 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Mycosis Fungoides
Lymphomatoid Papulosis
Sezary Syndrome

Interventions

DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]